{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T06:05:52Z","timestamp":1784009152488,"version":"3.55.0"},"reference-count":27,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:00:00Z","timestamp":1783987200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Prescription errors remain a significant challenge to medication safety in hospital settings. Forced Interception (FI) systems, which automatically flag and block potentially problematic prescriptions, serve as critical safeguards against adverse drug events. However, the specific characteristics and underlying causes of intercepted prescriptions, particularly in Chinese hospital contexts, require further investigation to inform targeted quality improvement strategies. This study aimed to analyze the characteristics and interception reasons of FI prescriptions in a hospital setting, with the goal of identifying patterns that could guide system upgrades, clinical training, and policy interventions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This study conducted a retrospective analysis of FI prescriptions intercepted by the hospital\u2019s electronic prescribing system. Prescriptions were analyzed for interception reasons, drug categories, specific medications, and prescribing department patterns. Data were collected and categorized to identify the most frequent issues and drug types involved in forced interceptions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of FI prescriptions were analyzed. The most common interception reasons were \"Treatment duration exceeded\" (54.89%) and \"Exceeding Dosage\" (28.11%), together accounting for the majority of interceptions. Traditional Chinese medicine and central nervous system drugs were the most frequently intercepted drug categories. The top three intercepted medications were Duloxetine Hydrochloride Enteric Capsules (3.63%), Atorvastatin Calcium Tablets (3.11%), and Tandospirone Citrate Capsules (2.81%). Departmental analysis revealed distinct prescribing patterns: the cardiology department showed high interceptions for hyperlipidemia-related drugs, while the mental health department had numerous interceptions for long-term antidepressant and anxiolytic prescriptions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>The study suggests that targeted interventions, including upgrading electronic prescribing systems, department-specific training, and forming special review panels, are necessary to reduce prescription errors and improve medication safety. Future work should focus on multicenter studies and, as a longer-term direction, explore the potential of artificial intelligence for dynamic risk prediction to enhance the continuous optimization of medical quality.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fphar.2026.1826012","type":"journal-article","created":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T05:38:51Z","timestamp":1784007531000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Descriptive analysis of prescription interception patterns: characterizing medication safety risks in an outpatient setting"],"prefix":"10.3389","volume":"17","author":[{"given":"Ning","family":"Li","sequence":"first","affiliation":[{"name":"Department of Clinical Pharmacy, The First Hospital of Jilin University","place":["Changchun, Jilin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiwei","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, The First Hospital of Jilin University","place":["Changchun, Jilin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, The First Hospital of Jilin University","place":["Changchun, Jilin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Gong","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, The First Hospital of Jilin University","place":["Changchun, Jilin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuhong","family":"Wei","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, The First Hospital of Jilin University","place":["Changchun, Jilin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiawei","family":"Gong","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, The First Hospital of Jilin University","place":["Changchun, Jilin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinghui","family":"Zhai","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, The First Hospital of Jilin University","place":["Changchun, Jilin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sixi","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, The First Hospital of Jilin University","place":["Changchun, Jilin, China"]},{"name":"School of Pharmaceutical Science, Jilin University","place":["Changchun, Jilin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1136\/ejhpharm-2024-004139","article-title":"Deep learning classification of drug-related problems from pharmaceutical interventions issued by hospital clinical pharmacists during medication prescription review: a large-scale descriptive retrospective study in a French university hospital","volume":"32","author":"Alkanj","year":"2025","journal-title":"Eur. J. Hosp. Pharm."},{"key":"B2","doi-asserted-by":"publisher","first-page":"20552076251388145","DOI":"10.1177\/20552076251388145","article-title":"Artificial intelligence in clinical pharmacy-A systematic review of current scenario and future perspectives","volume":"11","author":"Alqahtani","year":"2025","journal-title":"Digit. Health"},{"key":"B3","doi-asserted-by":"publisher","first-page":"e114519","DOI":"10.1371\/journal.pone.0114519","article-title":"Prediction of cardiovascular events in statin-treated stable coronary patients of the treating to new targets randomized controlled trial by lipid and non-lipid biomarkers","volume":"9","author":"Arsenault","year":"2014","journal-title":"PLoS One"},{"key":"B4","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1186\/s13643-020-01510-7","article-title":"The impact of health information technology on prescribing errors in hospitals: a systematic review and behaviour change technique analysis","volume":"9","author":"Devin","year":"2020","journal-title":"Syst. Rev."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1016\/S0140-6736(17)31047-4","article-title":"Medication without harm: WHO\u2019s third global patient safety challenge","volume":"389","author":"Donaldson","year":"2017","journal-title":"Lancet"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1111\/jocn.70109","article-title":"Assessing the effectiveness of interventions implemented by nurses to reduce medication administration errors in hospitalised acute adult patient settings: systematic review and meta-analysis","volume":"35","author":"Eze","year":"2026","journal-title":"J. Clin. Nurs."},{"key":"B7","doi-asserted-by":"publisher","first-page":"186","DOI":"10.3390\/medicina57020186","article-title":"Vitamin D and Glomerulonephritis","volume":"57","author":"Gembillo","year":"2021","journal-title":"Med. (Kaunas)"},{"key":"B8","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1053\/j.ajkd.2024.03.025","article-title":"Vitamin D metabolites before and after kidney transplantation in patients who are anephric","volume":"84","author":"J\u00f8rgensen","year":"2024","journal-title":"Am. J. Kidney Dis."},{"key":"B9","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1331\/JAPhA.2015.14151","article-title":"Rhabdomyolysis precipitated by possible interaction of ticagrelor with high-dose atorvastatin","volume":"55","author":"Kido","year":"2015","journal-title":"J. Am. Pharm. Assoc. (2003)"},{"key":"B10","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1186\/s12911-022-01978-4","article-title":"Detection of statin-induced rhabdomyolysis and muscular related adverse events through data mining technique","volume":"22","author":"Kunakorntham","year":"2022","journal-title":"BMC Med. Inf. Decis. Mak."},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1097\/CRD.0000000000000848","article-title":"Curbside consult optimizing Statin therapy in the elderly: a personalized approach to cardiovascular disease prevention","author":"Maheta","year":"2025","journal-title":"Cardiol. Rev"},{"key":"B12","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.therap.2025.10.001","article-title":"Artificial intelligence in personalized prescription: a narrative review of promise, peril, and practicality","volume":"81","author":"Martin","year":"2026","journal-title":"Therapie"},{"key":"B13","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1186\/s13018-023-03995-z","article-title":"Duloxetine for fibromyalgia syndrome: a systematic review and meta-analysis","volume":"18","author":"Migliorini","year":"2023","journal-title":"J. Orthop. Surg. Res."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1093\/jamia\/ocy076","article-title":"Effectiveness of provider price display in computerized physician order entry (CPOE) on healthcare quality: a systematic review","volume":"25","author":"Mummadi","year":"2018","journal-title":"J. Am. Med. Inf. Assoc."},{"key":"B15","doi-asserted-by":"publisher","first-page":"3207","DOI":"10.1038\/s41591-025-04033-7","article-title":"For trustworthy AI, keep the human in the loop","volume":"31","author":"Nature","year":"2025","journal-title":"Nat. Med."},{"key":"B16","doi-asserted-by":"publisher","first-page":"106362","DOI":"10.1016\/j.ijmedinf.2026.106362","article-title":"Human in the loop artificial intelligence in healthcare: applications, outcomes, and implementation challenges","volume":"213","author":"Olawade","year":"2026","journal-title":"Int. J. Med. Inf."},{"key":"B17","doi-asserted-by":"publisher","first-page":"102323","DOI":"10.1016\/j.xcrm.2025.102323","article-title":"Large language model as clinical decision support system augments medication safety in 16 clinical specialties","volume":"6","author":"Ong","year":"2025","journal-title":"Cell Rep. Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/s41746-026-02410-1","article-title":"Flight rules for clinical AI: lessons from aviation for human-AI collaboration in medicine","volume":"9","author":"Ong","year":"2026","journal-title":"NPJ Digit. Med."},{"key":"B19","doi-asserted-by":"publisher","first-page":"10","DOI":"10.2165\/1158822-S0-000000000-00000","article-title":"Pleiotropic effects of statins: evidence against benefits beyond LDL-Cholesterol lowering","volume":"10","author":"Pedersen","year":"2010","journal-title":"Am. J. Cardiovasc Drugs"},{"key":"B20","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.atherosclerosis.2020.12.023","article-title":"Combination of bempedoic acid, ezetimibe, and atorvastatin in patients with hypercholesterolemia: a randomized clinical trial","volume":"320","author":"Rubino","year":"2021","journal-title":"Atherosclerosis"},{"key":"B21","doi-asserted-by":"publisher","first-page":"287","DOI":"10.4103\/0971-4065.151352","article-title":"Duloxetine induced hyponatremia","volume":"30","author":"\u015eahan","year":"2019","journal-title":"Turk Psikiyatri Derg."},{"key":"B22","doi-asserted-by":"publisher","first-page":"E31","DOI":"10.1097\/NNE.0000000000001738","article-title":"360\u00b0 video simulation scenario for the WHO global patient safety challenge \u201cMedication Without Harm.\u201d","volume":"50","author":"Sousa","year":"2025","journal-title":"Nurse Educ."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1767646","DOI":"10.3389\/fphar.2026.1767646","article-title":"Closing the loop: human-augmented, mechanistically enhanced AI for proactive management of drug-drug interactions","volume":"17","author":"Spanakis","year":"2026","journal-title":"Front. Pharmacol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"2889","DOI":"10.1016\/j.jacc.2013.11.002","article-title":"2013 ACC\/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American college of cardiology\/American heart association task force on practice guidelines","volume":"63","author":"Stone","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"2671","DOI":"10.2174\/0113816128321623240719104337","article-title":"Prescription precision: a comprehensive review of intelligent prescription systems","volume":"30","author":"Tantray","year":"2024","journal-title":"Curr. Pharm. Des."},{"key":"B26","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1093\/ijnp\/pyz034","article-title":"Maintenance pharmacological treatment of juvenile bipolar disorder: review and meta-analyses","volume":"22","author":"Yee","year":"2019","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"31391","DOI":"10.1038\/s41598-025-16934-1","article-title":"Artificial intelligence-assisted quality control circles led by clinical pharmacists to improve the rational use of parenteral proton pump inhibitors among hospitalised patients","volume":"15","author":"Zhang","year":"2025","journal-title":"Sci. Rep."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1826012\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T05:38:52Z","timestamp":1784007532000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1826012\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,14]]},"references-count":27,"alternative-id":["10.3389\/fphar.2026.1826012"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2026.1826012","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,14]]},"article-number":"1826012"}}